Topics

FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data

21:48 EST 14 Jan 2020 | Xconomy

As the nation grapples with the ongoing opioid crisis, an FDA advisory panel on Tuesday unanimously voted against recommending approval of a Nektar Therapeutics painkiller that would add a new compound to the drug class—even though it was designed to reduce the risk of abuse. Some members of the panel, which was comprised mainly of […]

Original Article: FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data

NEXT ARTICLE

More From BioPortfolio on "FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...